This month’s positive vaccine news has dramatically improved the near term global economic outlook, but it doesn’t fundamentally alter our dovish view on EM monetary policy. Many EMs have only small (or non-existent) purchase agreements and face distributional hurdles, so near-term recoveries will still be bumpy and uneven as COVID-19 containment measures remain in place. If anything, the likely further improvement in risk appetite strengthens our view for more rate cuts in Mexico, India, Russia and Indonesia. Even in Chile and Central & Eastern Europe, whose economies could benefit most from the roll-out of vaccines, all the signs point to central banks staying focused on keeping policy loose for a prolonged period. Overall, our forecasts remain more dovish than those priced into markets.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services